Key statistics · As on 14 Oct 2026
Market cap
BDT 23,192.400 mn
Free float market cap
BDT 13,947.105 mn
NAV per share
BDT 28.86
P/E (audited)
24.56x
Day's value
BDT 5.01 mn
Day's volume
49,771
Day's trades
355
Opening price
BDT 101.80
Adjusted Opening Price
BDT 100.40
Yesterday's closing price
BDT 100.40
Closing price
BDT 100.70
Last Update
2:09 PM
Day's range
Current BDT 100.70
BDT 100.20BDT 101.80
52-week range
Current BDT 100.70
BDT 93.20BDT 117.90
Basics
- Listing year
- 2010
- Authorized Capital (mn)
- BDT 3,000
- Paid-up capital
- BDT 2,310.00 mn
- Face value
- BDT 10.00
- Total outstanding securities
- 231,000,000
- Market Lot
- 1
Shareholding pattern
as on Jun 30, 2025 (year ended)
as on Aug 31, 2026
as on Sep 30, 2026
Sponsor / Director
39.86%
39.86%
39.86%
Government
0.00%
0.00%
0.00%
Institution
38.90%
38.16%
38.36%
Foreign
0.00%
0.00%
0.05%
Public
21.24%
21.98%
21.73%
Shareholding percentages as reported by the listed company.
Sponsor/Director holdings reflect regulation 2(1)(r) of the DSE (Listing) Regulations 2015.
Corporate & contact
- Present Operational Status
- Active
- Head Office / Registered Office
- 9/B/2, Toyenbee Circular Road, Motijheel C/A, Dhaka-1000.
- Factory Address
- Khathali, Bhaluka, Mymensingh.
- Contact Phone
- +880-2-57165371-76, Ext-102
- Fax
- +880-2-57165379
- beacon@beaconpharma.com.bd
- Company Secretary Name
- Mr. Anindya Sarkar FCS
- Company Secretary Cell No.
- +88 01335 251144
- Company Secretary Telephone No.
- +880-2-57165371-76
- Company Secretary E-mail
- anindya@beaconpharma.com.bd
- Website
- www.beaconpharma.com.bd
- Loan status
- Short-term: BDT 6,884.34 mn · Long-term: BDT 3,193.10 mn
- Present Loan Status — as on
- —
- Credit rating
- Short-term: — · Long-term: —
- Last AGM
- 23-12-2025
- Year-end
- June
Details of Financial Statementhttps://beaconpharma.com.bd/investor-diary
Price Sensitive Informationhttps://beaconpharma.com.bd/investor-diary